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a b s t r a c t
The spike protein S of coronaviruses contains a highly conserved cytoplasmic cysteine-rich motif
adjacent to the transmembrane region. This motif is palmitoylated in the Betacoronaviruses MHV and
SARS-CoV. Here, we demonstrate by metabolic labeling with [3H]-palmitic acid that the S protein of
transmissible gastroenteritis coronavirus (TGEV), an Alphacoronavirus, is palmitoylated as well. This is
relevant for TGEV replication as virus growth was compromised by the general palmitoylation inhibitor
2-bromopalmitate. Mutation of individual cysteine clusters in the cysteine-rich motif of S revealed that
all cysteines must be replaced to abolish acylation and incorporation of S into virus-like particles (VLP).
Conversely, the interaction of S with the M protein, essential for VLP incorporation of S, was not impaired
by lack of palmitoylation. Thus, palmitoylation of the S protein of Alphacoronaviruses is dispensable for
S–M interaction, but required for the generation of progeny virions.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Coronaviruses (CoVs) are a family of enveloped, single-
stranded, positive-sense RNA viruses that have a broad host range,
as they infect a wide variety of avian and mammalian species
including humans. The family Coronaviridae is split up in four
genera, the Alpha-, Beta-, Delta- and Gammacoronavirus. The genus
Betacoronavirus comprises the prototype coronavirus mouse hepa-
titis virus (MHV) as well as the recently emerged human patho-
gens severe acute respiratory syndrome (SARS)-CoV and middle
east respiratory syndrome (MERS)-CoV. The genus Alphacorona-
virus includes important animal pathogens like feline infectious
peritonitis virus (FIPV), porcine epidemic diarrhea virus (PEDV),
and transmissible gastroenteritis virus (TGEV), which is the sub-
ject of this study. The positive-stranded RNA genome of corona-
viruses is associated with the N protein, building up the
nucleocapsid, which is surrounded by a lipid bilayer. The structural
proteins Spike (S), Membrane (M), and Envelope (E) protein are
embedded in this envelope.
Coronaviruses assemble at and bud into intracellular mem-
branes at the endoplasmic reticulum Golgi intermediate compart-
ment, ERGIC (Krijnse-Locker et al., 1994; Tooze et al., 1984).
Subcellular targeting signals in the viral proteins direct the
proteins towards the budding site (Corse and Machamer, 2002;
Lontok et al., 2004; Paul et al., 2014; Schwegmann-Wessels et al.,
2004; Swift and Machamer, 1991). Lateral protein interactions
between M and M (Locker et al., 1992), M and E (Lim and Liu,
2001), M and N (Narayanan et al., 2000), as well as M and S
(Opstelten et al., 1995) proteins play crucial roles during assembly
and trigger budding. This paper focuses on the S protein of TGEV.
This is a large type 1 membrane protein (250 kDa) that is
responsible for the attachment to the cellular receptor and sub-
sequent fusion of viral and cellular membranes. The S protein is
incorporated into virus particles by interaction with the M protein
(Nguyen and Hogue, 1997; Vennema et al., 1996). This is an
indispensable step in the CoV replication cycle to obtain infectious
virus particles.
Palmitoylation (S-acylation) is a post-translational modiﬁca-
tion, in which a saturated fatty acid (most commonly palmitic
acid) is linked to a cysteine residue by a thioester bond (Schmidt
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et al., 1988; Veit et al., 1991). This modiﬁcation can have effects on
protein activity (Huang et al., 2010), transport (Abrami et al., 2008,
2006), and stability (Abrami et al., 2006; Maeda et al., 2010). Most
of the cysteines that become acylated are located near the
transmembrane region (Veit, 2012; Yang and Compans, 1996; Yik
and Weigel, 2002). Palmitoylation of viral proteins has been shown
to affect virus assembly or virus replication (Bhattacharya et al.,
2004; Gaedigk-Nitschko et al., 1990).
CoV S proteins show a conserved cysteine rich motif (CRM) in
the cytoplasmic domain, adjacent to the carboxyterminal end of
the transmembrane region (Fig. 1). The CoV S proteins share little
sequence homology at this region but the cysteine content is about
35%. For the Betacoronaviruses SARS-CoV and MHV, it has been
shown that the S proteins are palmitoylated at the CRM (Petit
et al., 2007; Thorp et al., 2006). In both viruses the palmitoylation
of the S protein is implicitly necessary for the incorporation of the
S protein into virus-like particles (VLPs) or virus particles (Thorp
et al., 2006; Ujike et al., 2012). However, a partial CRM can be
sufﬁcient for the incorporation of the S protein (Ujike et al., 2012;
Yang et al., 2012). In contrast to that, the interaction of the S and M
proteins has different requirements in both viruses. Treatment
with the general palmitoylation inhibitor 2-bromopalmitate dis-
rupted the interaction of S and M proteins in MHV (Thorp et al.,
2006). Conversely, the SARS-CoV S–M protein interaction is not
impaired with a palmitoylation-null S protein cysteine-mutant
(McBride and Machamer, 2010).
These reported ﬁndings demonstrate the different require-
ments in the closely related viruses MHV and SARS-CoV that both
belong to the genus Betacoronavirus. We wanted to know whether
coronaviruses from the genus Alphacoronavirus differ from these
Betacoronaviruses with respect to their role of the S protein's CRM.
In our study we addressed the role of the S protein CRM of the
Alphacoronavirus TGEV during assembly. To this end, we substi-
tuted cysteines in the CRM of the TGEV S protein and assessed
their effect on VLP formation and on S–M protein interaction. We
show that in contrast to the SARS-CoV S protein the TGEV S
protein is incorporated into VLPs irrespective of the position of its
palmitoylated cysteines. For an efﬁcient interaction between TGEV
S and M proteins, palmitoylation of the S protein is not necessary.
Our results demonstrate that despite general similarities, corona-
viruses show differences regarding the functional role of S protein
palmitoylation that may have been induced by evolutionary forces.
Results and discussion
2-BP treatment decreases the infectivity of TGEV
The palmitate analog 2-bromopalmitate (2-BP) inhibits protein
palmitoylation in general (Webb et al., 2000). To investigate
whether palmitoylation has an impact on TGEV infectivity, we
performed a treatment with 2-BP (Fig. 2A). ST cells were infected
with TGEV and treated with different concentrations of 2-BP (0,
0.8, 4, 8, and 12 mM). Vesicular stomatitis virus (VSV, grown in
BHK-21 cells) was employed as a control since the assembly of this
virus does not depend on palmitoylation (Thorp et al., 2006; Whitt
and Rose, 1991). These 2-BP concentrations were not cytotoxic for
ST cells veriﬁed with a WST-1 cell proliferation assay (Fig. 2B).
About 24 h after infection, media were harvested and viral
infectivity was determined by plaque assay. The production of
infectious VSV particles was not signiﬁcantly inhibited by the 2-BP
treatment (Fig. 2A) (Thorp et al., 2006; Whitt and Rose, 1991). In
contrast to that, a signiﬁcant, dose-dependent decrease of TGEV
infectivity was observed upon 2-BP treatment. This decrease in
infectivity correlated with a decrease in the amount of virus
particles in the supernatant of 2-BP-treated, infected cells, as seen
by Western blot of pelleted supernatants for viral proteins
(Fig. 2C). The amount of protein expression in the cell lysates
was not inﬂuenced by 2-BP treatment (Fig. 2C). From these results,
we conclude that an inhibition of palmitoylation has negative
effects on the production of infectious TGEV (but not VSV)
particles. While we cannot exclude that the reduction in infectious
TGEV particle numbers upon 2-BP treatment is partially caused by
inhibited palmitoylation of an essential cellular factor, we con-
sidered it most likely that the palmitoylation of a viral protein is
required for the production of infectious virions. This led us to
assess whether the TGEV S protein is palmitoylated.
TGEV S is palmitoylated in virus particles
Recent studies have shown that the S proteins of MHV and
SARS-CoV, both members of the genus Betacoronavirus, are palmi-
toylated (McBride and Machamer, 2010; Petit et al., 2007; Shulla
and Gallagher, 2009; Thorp et al., 2006). The cysteine-rich motif
(CRM) is highly conserved among CoV S proteins, and a CRM is
also found in the S protein of TGEV as a member of the genus
Alphacoronavirus (Fig. 1). To determine whether the TGEV S
protein is also palmitoylated, TGEV was grown in ST cells in the
presence of [3H]-palmitic acid to achieve radioactive labeling,
followed by pelleting of the virus, SDS-PAGE and ﬂuorography.
This revealed that the S protein of TGEV is indeed S-acylated,
visible by the band at about 250 kDa which was absent in
uninfected cells (Fig. 2D). The speciﬁcity of this labeling with
[3H]-palmitic acid was conﬁrmed by hydroxylamine treatment
(Fig. 2D). Hydroxylamine cleaves thioester linkages at neutral
pH and thus any palmitic acid linked to a cysteine residue by
S-acylation. The disappearance of the TGEV S protein band after
hydroxylamine treatment proves that this protein is S-acylated at
at least one cysteine residue.
Fig. 1. Sequence alignment of the carboxy-terminal S protein sequences from representative coronavirusspecies. Underlined cysteine residues represent potential
palmitoylation sites. TGEV–PUR-46 (transmissible gastroenteritis virus, strain PUR-46), FIPV (feline infectious peritonitis virus), HCoV-NL-63 (human coronavirus NL63),
SARS-CoV (severe acute respiratory syndrome coronavirus), MHV-A59 (mouse hepatitis virus, strain A59), MERS-CoV (middle east respiratory syndrome coronavirus), IBV
Beaudette (infectious bronchitis virus, strain Beaudette), Bul-CoV (bulbul coronavirus).
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Palmitoylation of TGEV S is necessary for incorporation into VLPs
As the infectivity of TGEV was reduced after 2-BP treatment
and the S protein present in TGE virions was shown to be
palmitoylated, we concentrated our analysis on the cysteine-rich
motif (CRM) present in the cytoplasmic domain of the TGEV S
protein (Fig. 1). The Swt protein of the TGEV–PUR-MAD strain
contains 10 cysteine residues within the CRM (Sanchez et al.,
1990). The CRM of TGEV S can be split up in three cysteine clusters
with three to four cysteine residues (Fig. 1). To test whether
speciﬁc cysteine clusters have a crucial role during virus assembly,
partial Cys-mutants were created in addition to the complete
cysteine mutant where all cysteines were replaced by alanines
(S_C1–10A, Fig. 3A). As the transfection efﬁciency of ST cells is quite
low, BHK-21 cells were transfected with the plasmids encoding for
the different Cys-mutants. The labeling with [3H]-palmitic acid
showed that all partial mutants were palmitoylated whereas the
complete Cys-mutant was not palmitoylated (Fig. 3B). The pre-
sence of three cysteines in the CRM (S_C1–7A) was hence sufﬁcient
for the protein to be acylated even if the degree of palmitoylation
was lower for this mutant (Fig. 3B). It is conceivable that
palmitoylation of the CRM cysteines is important for fusion, which
is mediated by the S protein. The importance of the CRM of the
MHV and SARS-CoV S proteins for fusion has already been proven
(Bos et al., 1995; Chang et al., 2000; McBride and Machamer, 2010;
Shulla and Gallagher, 2009). In this study, we however evaluated
Fig. 2. Palmitoylation of TGEV. (A) Treatment with 2-bromopalmitate (2-BP) decreases the infectivity of TGEV. ST or BHK-21 cells were inoculated with TGEV or VSV,
respectively. At 1 h p.i., media were replaced with growth media containing the indicated concentrations of 2-BP or ethanol as 2-BP solvent (ethanol control: amount of
ethanol present in the highest 2-BP concentration; 0.0 mM 2-BP: mediumwithout ethanol). Twenty-four hours later, media were collected and the amount of infectious virus
particles was determined by plaque assay. Plaque forming units (PFU)/ml are displayed as meanþstandard deviation (SD). n, signiﬁcantly different according to Student's t
test compared to 0.0 mM 2-BP (po0.05). (B) 2-BP is not cytotoxic to ST cells at the concentrations used. ST cells were treated with the indicated concentrations of 2-BP and
cell proliferation was determined by WST 1-assay. The cell proliferation is indicated as meanþSD in percentage. (C) The amount of viral proteins present in viral particles is
reduced after 2-BP treatment. Virions from cell culture supernatants of infected cells, treated with the indicated amounts of 2-BP, were pelleted by ultracentrifugation 24 h
p.i. and analyzed by SDS-PAGE and Western blotting (virions). The indicated proteins (S, N, and M) were detected by monoclonal antibodies. The corresponding cells were
lysed and the respective proteins were equally analyzed (cell lysates). (D) Palmitoylation of the TGEV S protein in virus particles. Infected and mock-infected ST cells were
labeled with [3H]-palmitic acid or [35S]-methionine/cysteine. Radiolabeled virus was analyzed by SDS-PAGE and ﬂuorography. A hydroxylamine treatment was performed to
determine the linkage of fatty acids via a thioester bond.
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whether palmitoylation is important for assembly and incorpora-
tion of the spike protein into newly generated virus particles. To
analyze this role a virus-like particle assay was performed in
which the incorporation of S can be analyzed separately from the
inﬂuence of the fusion capacity of the S protein. The incorporation
of the TGEV S protein is an essential step during assembly to form
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infectious particles. To determine the importance of the TGEV S
protein's CRM during virus assembly we analyzed the capability of
the TGEV S Cys-mutants to be incorporated into virus-like parti-
cles (VLPs, Fig. 3D and E). The co-expression of the TGEV E and M
proteins is the minimal requirement for VLP formation (Baudoux
et al., 1998). If the S protein is co-expressed with M and E it will be
incorporated into VLPs (Vennema et al., 1996). In contrast to the
authentic TGEV S protein the complete Cys-mutant S_C1–10A was
not incorporated into VLPs (Fig. 3D). The analyzed partial Cys-
mutants S_C1–3A, S_C4–7A, S_C8–10A, and S_C1–7A behaved like the
TGEV Swt protein and were incorporated into VLPs (Fig. 3D). To
conﬁrm these results and to account for variations in protein levels
in Western blots, we additionally performed immunoﬂuorescence
analysis to show the cell surface transport of S protein (Fig. 3E).
We obtained comparable intracellular expression levels of all
tested TGEV S proteins and the TGEV M protein. Like in the VLP
assay analyzed by Western blot, the S_C1–10A mutant was the only
S protein which was not detectable on the cell surface and
therefore not incorporated into VLPs (Fig. 3E). These results
demonstrate that cysteines are important for the S protein
incorporation into viral particles, and that they are at least
partially redundant. In contrast to the reports for SARS-CoV
(Ujike et al., 2012), the speciﬁc position of the cysteine residue
inside the cysteine-rich region seems not to be relevant for the
incorporation into VLPs. The presence of one cluster of 3 cysteines
(S_C1–7A) is enough to incorporate S into VLPs.
The S proteins of coronaviruses are known to form trimers
(Delmas and Laude, 1990). To exclude that the inability of the
complete Cys-mutant to incorporate into VLPs is caused by a
defect in oligomerization, we analyzed the quaternary structure of
S_C1–10A with a sucrose density gradient and compared it with the
TGEV Swt protein. The results showed that the wild type protein
and the Cys-mutant are both detectable in high-concentration
sucrose fractions indicating a comparable oligomerization poten-
tial (Fig. 3C). In conclusion, the palmitoylation of the TGEV S is
necessary for the incorporation of the S protein into VLPs, but does
not affect oligomerization of S.
How does palmitoylation of the TGEV S protein inﬂuence S
incorporation?
One possible explanation might be that the conformation of the
cytoplasmic tail of the S protein is crucial for the incorporation of S
protein into virus particles. The palmitic acids probably help in
membrane attachment of the cytoplasmic tail and may thus deﬁne
its conformation. This conformation may play a minor role in the
binding to the M protein but may be important for the incorpora-
tion of the TGEV S protein into virus-like particles. It is possible
that the linked fatty acids determine how the protein is positioned
in the ERGIC membrane and how it is inserted in the dense matrix
formed by the lateral M–M interactions described for coronavirus
assembly (de Haan et al., 2000; Neuman et al., 2006).
The palmitoylation of proteins can concentrate them at certain
membrane domains (Heakal et al., 2011). A lot of viruses use
palmitoylation to target their proteins to lipid microdomains at the
plasma membrane for assembly (Bhattacharya et al., 2004; Zhang
et al., 2000). Palmitoylated proteins concentrate with interacting
proteins at intracellular microdomains as well. As examples, the
chaperon Calnexin and the transmembrane thioredoxin protein
are recruited to detergent-resistant membranes of the endoplas-
mic reticulum by palmitoylation (Hayashi and Fujimoto, 2010;
Lynes et al., 2012). Thus, a version of the TGEV S protein like the
complete Cys-mutant S_C1–10A that lacks palmitic acids may
interact with the M protein in an S–M protein co-expression
experiment but may not be sorted to the membrane microdo-
mains at the ERGIC in which virus assembly and budding take
place and may therefore not be incorporated into newly generated
virions or VLPs. McBride and Machamer have shown that the
SARS-CoV S protein is present in DRMs at the plasma membrane in
single expression experiments. For a complete Cys-mutant of the
SARS-CoV S protein it was shown that it is no longer present in
DRMs (McBride and Machamer, 2010). These results conﬁrm the
hypothesis that the palmitoylation of coronavirus S proteins
directs them to membrane microdomains and that this localiza-
tion is indispensable for the incorporation into VLPs and virions.
Palmitoylation of TGEV S is dispensable for interaction with
the M protein
Lateral protein interactions play important roles during virus
assembly. The interaction of S and M proteins is essential for the
incorporation of S into virus particles. Thus, we aimed to ﬁnd out
whether the palmitoylation of S is required for the interactionwith the
M protein (as in the case of MHV;(Shulla and Gallagher, 2009; Thorp
et al., 2006)), or not (as for SARS-CoV;(McBride and Machamer, 2010;
Ujike et al., 2012)). To determine this, we expressed M (with HA-tag)
together with the various cysteine mutants of S, with the background
of a destroyed ERGIC retention signal (Y/A, Fig. 4A). With this Y/A
mutation, S is efﬁciently transported to the plasma membrane in the
absence of M, but is retained intracellularly by M (Fig. 4B and C).
Failure of S_Y/A cysteine mutants to interact with M thus leads to
plasmamembrane delivery of S even in the presence of M. The TGEV S
variants depicted in Fig. 4A were expressed in BHK-21 cells by
transfection, in the absence or presence of HA-tagged TGEV M.
Immunoﬂuorescence analysis was employed to assess the localization
of S andM. All partial Cys-mutants and even the complete Cys-mutant
showed a similar protein localization pattern with the M protein
(Fig. 4B and C). This pattern was identical to the one seen for the S
wildtype protein in coexpression with the HA-tagged M protein (S wt,
Fig. 4B and C). In contrast to that, the VSV G protein was not retained
and not intracellularly clustered by the co-expression of HA-tagged
TGEV M protein (VSV G, Fig. 4B and C). These results indicate that
speciﬁc interactions between the TGEV S and M proteins lead to an
intracellular retention of the mutant S proteins and that the interac-
tion of TGEV S and M proteins is not dependent on the palmitoylation
of S. Palmitoylation is known to affect protein trafﬁcking (Greaves
and Chamberlain, 2007; Resh, 1999, 2006). Our results show that
this is not the case for the TGEV S since the full cysteine-mutant with
Fig. 3. Palmitoylation of S is necessary for incorporation into VLPs. (A) Schematic illustration of TGEV S wild-type and TGEV S cysteine-mutants. The cysteine-rich motif
(CRM) and the tyrosine-based retention signal are highlighted by boxes. Cysteines substituted by alanines are written in bold. ED, ectodomain; TMD, transmembrane
domain; CD, cytoplasmic domain. (B) The complete TGEV S cysteine-mutant is not palmitoylated, whereas the partial cysteine-mutants are. BHK-21 cells expressing TGEV
Swt or the indicated TGEV S cysteine-mutants were labeled with [3H]-palmitic acid or [35S]-methionine/cysteine for 5 h. The cells were lysed and S protein was
immunoprecipitated and subjected to SDS-PAGE and ﬂuorography. (C) Lack of cysteines in the CRM does not affect oligomerization. BHK-21 cells expressing TGEV Swt or
S_C1–10A were labeled with [35S]-methionine/cysteine for 6 h, then solubilized in 6 mM dodecyl-β-m-maltoside. A sucrose density gradient was overlaid with these cell
lysates and was ultracentrifuged. Fractions were collected, immunoprecipitated, and subjected to SDS-PAGE and phosphorimaging. (D) TGEV Swt and partial TGEV S
cysteine-mutants can be incorporated into VLPs, whereas a complete TGEV S cysteine-mutant cannot. BHK-21 cells were transfected with expression plasmids for the
indicated versions of TGEV S, and for TGEV M and E proteins (þ) or a mock expression plasmid (). At 24 h p.t., VLPs were collected by ultracentrifugation through a sucrose
cushion, and analyzed by SDS-PAGE and Western blotting. The corresponding cell lysates were checked for the presence of the respective proteins. (E) The TGEV S protein is
detectable on the cell surface of BHK-21 cells after co-expression of S, M, and E proteins. BHK-21 cells were transfected with expression plasmids for the indicated versions of
TGEV S alone or together with TGEV M and E encoding plasmids. At 24 h p.t., the S protein expression was detected by cell surface immunostaining or staining after
permeabilization of the cells. In addition to the TGEV S protein the TGEV M protein was detected intracellularly in the parallel co-expression experiment.
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Y/A-mutation trafﬁcs correctly to the cell surface in single expression
(Fig. 4C) and the full cysteine-mutant has a comparable oligomeriza-
tion potential as the wildtype protein (Fig. 3C).
Studies on MHV showed that the cytoplasmic tail of the S
protein and, more speciﬁcally, the membrane adjacent cysteine-
rich region is important for the interaction with M and for
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incorporation into virus-like particles (Bosch et al., 2005; Godeke
et al., 2000). Our results for TGEV are similar to the published
results for the SARS-CoV S protein, where the cysteine-rich motif is
not important for the interaction between S and M proteins
(McBride and Machamer, 2010). For these coronaviral spike
proteins other parts like the transmembrane domain or the
ectodomain of S could play a role in the interaction with the M
protein.
Conclusion
It is of signiﬁcant interest to understand how the S protein is
incorporated into coronavirus particles because the S protein
mediates binding to the cellular receptor and fusion with the
cellular membrane and is therefore indispensable for the genera-
tion of infectious virus particles. One important result from our
study is that the palmitoylation of the cysteine-rich motif at the
carboxy-terminus of the TGEV S protein is necessary for the
incorporation of S into virus-like particles. Furthermore, our
results suggest that the loss of palmitoylation does not affect the
interaction with the TGEV M protein. Here, we show that for TGEV,
the interaction of the S protein with M has different requirements
than the incorporation of S into virus particles.
This is the ﬁrst study about the role of palmitoylation in virus
assembly for the genus Alphacoronavirus in the family Coronavir-
idae, demonstrating that there are some similarities but also
differences in the requirements for coronavirus assembly in MHV
(Shulla and Gallagher, 2009; Thorp et al., 2006; Yang et al., 2012),
SARS-CoV (McBride and Machamer, 2010; Ujike et al., 2012), and
the Alphacoronavirus TGEV (Fig. 4D).
Future studies about the role of palmitoylation of the TGEV S
protein in virus assembly should include the analysis of recombi-
nant virions that contain the respective cysteine mutations.
Additionally it should be analyzed if the TGEV S protein is directed
to distinct membrane microdomains inside the ERGIC and if this
localization is determined by cysteine palmitoylation.
Materials and methods
Cells
BHK-21 cells were grown in Eagle's minimal essential medium
(EMEM; Gibco BRL) supplemented with 5% fetal calf serum (FCS;
Biochrom). ST (swine testicular) cells were propagated in Dulbec-
co's minimal essential medium (DMEM; Gibco BRL) containing 10%
Mycoplex fetal bovine serum (GE Healthcare).
Plasmid DNAs, construction of plasmids
The TGEV S gene, strain PUR-46-MAD (Sanchez et al., 1990),
was cloned into the pCG1 plasmid using BamHI and PstI restriction
sites (Cathomen et al., 1995; Schwegmann-Wessels et al., 2006).
Cysteine mutants of TGEV S protein and TGEV S_Y/A protein were
generated by a standard hybridization PCR technique, as described
previously (Schwegmann-Wessels et al., 2004). The generated
cysteine mutant proteins are illustrated in Figs. 3A and 4A.
An HA-peptide (MYPYDVPDYA) was C-terminally fused to the
TGEV M protein using standard PCR techniques. The mutated gene
regions generated by PCR were veriﬁed by sequencing (Euroﬁns
MWG Operon).
Transient transfections (PEI and Lipofectamine)
Transfection of BHK-21 cells in 6- and 24-well-plates was
performed by using Lipofectamine 2000 reagent (Life Technolo-
gies) following the manufacturer's instructions. BHK-21 cells in
10 cm-diameter dishes were transfected by using Polyethyleni-
mine (PEI; Polysciences). Transfections were carried out at a
conﬂuency of 70–80%. The medium was replaced with 7 ml fresh
EMEM containing 3% FCS. A total of 12 mg DNA were pipetted in
3 ml Opti-MEM (Life Technologies) and were incubated for 5 min.
Then, 20 ml of a 1 mg/ml PEI-working solution was added. The
mixture was incubated for 15 min at room temperature and added
to the cells.
2-bromopalmitate treatment and plaque assay
TGEV was propagated on ST cells and VSV (strain Indiana) on
BHK-21 cells. Infections were carried out on conﬂuent monolayers
with an MOI of 0.001 at 37 1C on a rocking shaker. At 1 h p.i. media
were removed and cells rinsed with PBS to prepare for further
treatments. For 2-bromopalmitate (2-BP) treatment infected cells
were grown in DMEM containing variable amounts of 2-BP (0, 0.8,
4, 8, and 12 mM) or ethanol (solvent of 2-BP). At a detectable
cytopathic effect supernatants were harvested and spun at 2800g
for 10 min at 4 1C to remove cellular debris. The amount of
infectious virus particles was determined by plaque assay as
described by Krempl et al. (2000) using ST cells (TGEV) or BHK-
21 cells (VSV). The cytotoxicity of the 2-BP treatment on ST cells
was quantiﬁed with the cell proliferation reagent WST-1 (Roche)
in 96-well microplates according to the manufacturer's instruc-
tions. Viral proteins (S, M, and N) incorporated into virions were
detected via SDS-PAGE and Western blot analysis after ultracen-
trifugation of the respective cell culture supernatants. S protein
was detected with mAB 6A.C3 (1:200), N protein with anti-
coronavirus monoclonal antibody FIPV3-70 (1:1000, Thermo
Scientiﬁc), and M protein with mAB 9D.B4 (1:200) followed by
incubation with an anti-mouse peroxidase-conjugated antibody
(Dako; 1:1000). Protein expression in the cells was equally
detected after cell lysis.
Labeling of viral particles with [3H]-palmitic acid
ST cells in 15 cm-diameter dishes were mock-infected or
infected with TGEV at an MOI of 10. At 3 h p.i. the cells were
labeled with 20 mCi/ml [3H]-palmitic acid ([9,10-3H(N)], Perkin-
Elmer) or [35S]-Met/Cys (EasyTagExpress mix, Perkin-Elmer) in
Met/Cys-free Dulbecco's modiﬁed Eagle's medium (DMEM; PAN
Biotech) supplemented with 5 mM L-glutamine (PAN Biotech). At
24 h p.i supernatants were harvested and cleared by low-speed
centrifugation (3000g, 20 min, 4 1C) followed by pelleting of the
virus by ultracentrifugation in an SW28m rotor (Beckman Coulter)
at 28,000 rpm for 2 h at 4 1C. The pellet was resuspended in 2
Fig. 4. Palmitoylation of TGEV S is dispensable for interaction with the M protein. (A) Schematic illustration of TGEV S_Y/A and TGEV S cysteine-mutants with Y/A-mutations.
The cysteine-rich motif (CRM) and the destroyed tyrosine-based retention signal are highlighted. Substitutions by alanine are written in bold. ED, ectodomain; TMD,
transmembrane domain; CD, cytoplasmic domain. (B) Every TGEV S cysteine-mutant shows an intracellular clustering in co-expression with the HA-tagged TGEV M protein.
BHK-21 cells expressing either the S proteins alone (mutants shown in A, S wt, or VSV G) or in co-expression with the TGEV M protein were permeabilized with Triton-X 100
prior to antibody incubation. The same ﬁeld is shown in each set of images for the coexpression of S and M. (C) Every TGEV S cysteine-mutant is retained intracellularly when
co-expressed with the HA-tagged TGEV M protein. The S protein (or the VSV G protein) was detected on the cell surface of non-permeabilized BHK-21 cells expressing either
the S proteins alone or in co-expression with the TGEV M. The detection of the HA-tagged TGEV M protein was done after permeabilization with Triton-X 100 prior to
antibody incubation. The same ﬁeld is shown for the detection of surface-expressed S together with the total M staining. (D) Comparison of the role of coronaviral S protein
palmitoylation for MHV (references indicated), SARS-CoV (references indicated), and TGEV (this study) for S–M protein interaction and S incorporation into VLPs or virions.
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non-reducing SDS sample buffer (0.1 M Tris–HCl, 2% SDS, 20%
glycerol, 2% bromophenol blue) and analyzed by SDS-PAGE and
ﬂuorography, as described previously (Thaa et al., 2011). To
determine an ester-type linkage of the acylated viral protein a
hydroxylamine treatment under neutral pH conditions was per-
formed, as described previously (Veit et al., 2008).
Metabolic labeling with [3H]-palmitic acid and immunoprecipitation
BHK-21 cells grown in 6-well-plates were transfected with
TGEV S expression plasmids using Lipofectamine 2000. Twenty-
four hours post-transfection, cells were washed with phosphate-
buffered saline (PBS) and incubated for 1 h in Met/Cys-free DMEM
supplemented with 5 mM L-glutamine. Subsequently, cells were
labeled for 5 or 19 h with 1000 mCi/ml [3H]-palmitic acid. A
parallel dish was labeled with 600 μCi/ml [35S]-Met/Cys. Cells
were lysed in NP-40 lysis buffer (0.5% sodium deoxycholate, 1%
Nonidet P40, 150 mM NaCl, 50 mM Tris–HCl, pH 7.5) containing
protease inhibitor (Complete, Roche) for 30 min at 4 1C. Lysates
were clariﬁed for 30 min at 20,000g, 4 1C. S protein was immuno-
precipitated with mouse anti-TGEV S monoclonal antibody, 6A.C3
(Gebauer et al., 1991) and protein A-sepharose (Sigma) overnight
at 4 1C. Immunoprecipitates were washed three times with NP-40
lysis buffer and were eluted in 2 non-reducing SDS sample
buffer at 96 1C for 10 min followed by SDS-PAGE and ﬂuorography.
Indirect immunoﬂuorescence microscopy
BHK-21 cells grown on coverslips in 24-well-plates were
co-transfected with pCG1-TGEV-S wt, pCG1-TGEV-S_Y/A, pCG1-
TGEV-Cys-mutants, pCG1-VSV-G with empty vector (pCG1) or
with HA-tagged pCG1-TGEV-M. The transfection ratio of S to M
was 5:1. At 18 h p.t. cells were ﬁxed with 3% paraformaldehyde in
PBS and indirect immunoﬂuorescence analysis was performed. For
intracellular protein detection cells were permeabilized with 0.2%
Triton/PBS for 5 min. Detection of TGEV S protein was performed
as described previously (Schwegmann-Wessels et al., 2004). The
VSV G protein was detected with the monoclonal antibodies I-1
and I-14 (Hanika et al., 2005). As secondary antibody, a Cy3-
conjugated sheep–anti-mouse antibody (1:300, Sigma) was used.
The HA-tagged TGEV M was visualized by an anti-HA-tag antibody
(rabbit, 1:200, Sigma) and anti-rabbit ﬂuorescein isothiocyanate
(FITC)-labeled secondary antibody (goat anti-rabbit, 1:300, Sigma).
Fluorescence micrographs were acquired on a Nikon Eclipse Ti
microscope. For the detection of S protein present in VLPs on the
cell surface plasmids encoding for the respective S proteins were
co-transfected with TGEV M and E plasmids. The immunostaining
was performed as described above with and without permeabili-
zation of the cells.
VLP-assay
BHK-21 cells grown in 10 cm-diameter dishes were co-
transfected with plasmids (pCG1) encoding the TGEV M, E and S
proteins. At 24 h p.t. VLPs secreted into the culture medium were
puriﬁed through a 25% sucrose cushion by ultracentrifugation at
35,000 rpm in an SW 41 rotor (Beckman Coulter) for 1 h at 4 1C.
VLP pellets were solubilized in 50 ml 2 SDS sample puffer and
subjected to SDS-PAGE. Cells were lysed in NP-40 lysis puffer and
were also subjected to SDS-PAGE. SDS gels were transferred by a
semi-dry technique (Kyhse-Andersen, 1984) to nitrocellulose
membranes (GE Healthcare) that were subsequently blocked over-
night with 1% blocking reagent (Roche) in blocking buffer (100 mM
maleic acid, 150 mMNaCl, pH 7.5). S protein was detected with mAB
6A.C3 (1:200) and M protein with mAB 9D.B4 (1:200) followed by
incubation with an anti-mouse peroxidase-conjugated antibody
(Dako; 1:1000). The nitrocellulose membrane was incubated with
a chemiluminescent peroxidase substrate (Thermo Scientiﬁc),
and chemiluminescence was measured with a Chemi Doc system
(Biorad).
Cell lysate fractionation on sucrose density gradients
BHK-21 cells were seeded in 10 cm-diameter dishes and were
transfected with pCG1-TGEV-Swt, pCG1-TGEV-S_C1–10A or empty
vector (pCG1) one day later. At 24 h p.t. the cells were metaboli-
cally labeled with 100 mCi/ml [35S]-Met/Cys in methionine- and
cysteine-free Dulbecco's modiﬁed Eagle's medium (Gibco) supple-
mented with 4 mM L-glutamine (PAA Laboratories) for 6 h. The
cells were solubilized in 250 ml 6 mM dodecyl-β-m-maltoside
(Sigma), 10 mM Tris, 150 mM NaCl, pH 7.5, and protease inhibitors
(Complete; Roche) per dish. The cell lysates were homogenized by
a needle (G211, 5″) and lysed for 3 h at 4 1C. One milliliter of the
cell lysate was loaded onto a sucrose gradient that consisted of a
50%-sucrose-cushion at the bottom of the tube overlaid with a
gradient of 10–30% sucrose (in 10 mM Tris, 150 mM NaCl, pH 7.5,
6 mM dodecyl-β-m-maltoside, and protease inhibitor). The gradi-
ent was centrifuged at 35,000 rpm for 18 h in an SW40 Ti rotor at
4 1C (Beckman Coulter) and then divided into 700 ml fractions.
700 ml NP-40 lysis buffer was added and S proteins were isolated
by immunoprecipitation. The radioactively labeled proteins were
analyzed in SDS-PAGE and were visualized by phosphorimaging
(Molecular Imager FX phosphoimager; Biorad).
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